Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof

A solid pharmaceutical tablet composition, comprising:

• 44% to 89% of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof;
• 6% to 51% of at least one selected from the group consisting of mannitol, sorbitol, and isomaltose;
• 3% to 5% of a disintegrant selected from the group consisting of carmellose, carmellose calcium, croscarmellose sodium, low-substituted hydroxypropylcellulose, sodium carboxymethyl starch, partially pregelatinized starch, crospovidone, and a combination thereof;
• and
• 1% to 2% of a lubricant selected from the group consisting of magnesium stearate, sodium stearyl fumarate, and a combination thereof.